Michael Meyers is Managing Director and Head of Investment Banking at T.R. Winston & Company, with over 25 years of experience in life sciences investment banking, venture capital and asset management. Prior to joining T.R. Winston, Meyers was the CEO and CIO of Arcoda Capital Management LP.
Prior to founding Arcoda in 2007, Meyers was a Partner and Portfolio Manager with GoldenTree Asset Management LP, a $22 billion multi-strategy asset management firm. Between 2002 and 2006, Meyers was a founding Managing Partner and Portfolio Manager of Trivium Capital Management LLC. Between 2000 and 2003, he was a Managing Director, Partner and member of the Board of Global Biomedical Partners AG, a life sciences venture capital firm located in New York and Zurich that was acquired by HBM Bioventures in 2003. Prior, Meyers was Director and Relationship Manager, Biotechnology and Pharmaceutical Investment Banking with Merrill Lynch & Co. He was also a Vice President of Health Care Investment Banking with Cowen & Company.
Meyers began his career as a Biotechnology and Medical Device Research Associate at Hambrecht & Quist in New York. Meyers serves on the Board of Trustees of the Ronald Reagan UCLA Medical Center, the University of Southern California’s Board of Councilors of the Stevens Center for Innovation and the School of Dramatic Arts, and the Board of Directors of The JED Foundation. He holds an MPH in Health Policy and Management from Columbia University and an AB in Biology from Brandeis University.